Enter your login e-mail to the account
Search
- K problematike neurodegeneratívnych ochorení
prof. MUDr. Pavel Varsik, DrSc., prof. MUDr. Jozef Černáček, DrSc., MUDr. Zoltán Goldenberg, prof. MUDr. Pavol Traubner, Ph.D.
(1/2002, Review articles ) - Botulotoxin a jeho role v léčbě neurologických onemocnění
MUDr. Petr Kaňovský, CSc.
(1/2001, Main topic )
- Childhood acute leukemia
doc. MUDr. Emília Kaiserová, CSc., MUDr. Alexandra Kolenová, PhD.
(4/2012, Review articles )
- CARDIOVASCULAR COMPLICATIONS OF SELECTED ANTICANCER AGENTS – NEW INSIGHTS INTO PATHOGENESIS AND DIAGNOSTICS
doc. MUDr. Beáta Mladosievičová, CSc., MUDr. Silvia Cingelová
(1/2008, Review articles ) - Biological treatment and chronic myeloid leukemia
prof. MUDr. Elena Tóthová, CSc.
(1/2011, Review articles ) - Tyrosine kinase inhibitor sunitinib malate
MUDr. Patrick Palacka, PhD., MPH, MBA
(3/2013, Drugs & drug classes ) - Novinky z ASCO 2006
MUDr. Tomáš Šálek, MUDr. Radovan Barilla,
(3/2006, Events ) - Simultaneous bi-lineage hematological malignancy in pediatric patient – case report
MUDr. Kristína Horváthová, MUDr. Helena Fillová, MUDr. Ivana Fedoráková, MUDr. Michal Šprlák, MUDr. Júlia Horáková, PhD.
(5/2024, Main topic ) - Cytogenetic and molecular cytogenetic methods in hemato-oncology
Mgr. Petra Nováková, MUDr. Denisa Ilenčíková, PhD.
(2/2010, Review articles ) - Molecular markers of targeted therapy in oncology malignancies
RNDr. Katarína Hlinková
(2/2010, Review articles ) - Acute myeloblastic leukemia in Slovakia and the presence of the FLT3 mutation
MUDr. Eva Mikušková, PhD.
(2/2021, Original articles ) - Myelofibrosis – diagnosis, management, new treatment options
MUDr. Anna Vallová
(6/2015, Review articles ) - Future of treatment of chronic myeloid leukemia (CML)
prof. MUDr. Elena Tóthová, CSc., MUDr. Adriana Kafková, PhD.
(5/2012, Main topic ) - Myelodysplastic syndrome – classification, pathophysiology
prof. MUDr. Elena Tóthová, CSc.
(1/2014, Spectrum ) - First line treatment of metastatic renal cell cancer in 2014
MUDr. Mária Rečková
(4/2014, Main topic ) - Správa z 15. kongresu Európskej hematologickej spoločnosti v Barcelone
MUDr. Ľudmila Demitrovičová
(5/2010, Events ) - The incidence and management of side effects of tyrosinekinase inhibitors for treatment of chronic myeloid leukemia
prof. MUDr. Elena Tóthová, CSc., MUDr. Adriana Kafková, PhD.
(1/2015, Review articles ) - FLT3mutácie u pacienta s AML: incidencia, možnosti diagnostiky a vplyv na manažment liečby
MUDr. Eva Mikušková, PhD., RNDr. Renata Lukačková, RNDr. Imrich Hikkel, PhD., Mgr. Michaela Zrubcová
(3/2018, Original articles & case reports ) - Gilteritinib for the treatment of relapsed and/or refractory FLT3-mutated acute myeloid leukemia
MUDr. Juraj Chudej, PhD., MBA, doc. MUDr. Juraj Sokol, PhD., MBA, MUDr. Ľudmila Lineková, MUDr. Monika Péčová, MUDr. Lenka Lisá, PhD.
(2/2023, Review articles ) - Childhood acute lymphoblastic leukemia: from genome to patient
doc. MUDr. Alexandra Kolenová, PhD.
(1/2016, Main topic ) - Therapy for chronic myeloid leukemia: Past, present and future
prof. MUDr. Elena Tóthová, CSc.
(1/2012, Topic of the year ) - New trends in diagnosis and treatment of essential thrombocythemia and myelofibrosis
prof. MUDr. Elena Tóthová, CSc., MUDr. Adriana Kafková, PhD.
(6/2012, Review articles ) - Treatment of patients with FLT3 positive acute myeloblastic leukemia
MUDr. Firas Farkaš, PhD., doc. MUDr. Martin Mistrík, PhD., prof. MUDr. Angelika Bátorová, PhD.
(6/2019, Review articles ) - Acute promyelocytic leukemia - pathogenesis, diagnostics, prognosis (part I.)
MUDr. Iveta Oravcová
(3/2009, Review articles ) - Decision making about the treatment of older patients with acute myeloblastic leukemia – case reports
MUDr. Iveta Oravcová, PhD., MUDr. Eva Mikušková, PhD., MUDr. Ľudmila Demitrovičová, PhD., MUDr. Vanda Mikudová, MUDr. Silvia Cingelová, PhD., doc. MUDr. Ľuboš Drgoňa, CSc.
(1/2018, Original articles & case reports ) - Nintendanib – new triple inhibitor of angiokinases in 2nd line of NSCLC
MUDr. Zuzana Pribulová
(2/2016, Drugs & drug classes )
- Nové liečivá v EÚ registrované v roku 2014 (II.)
Mgr. Zuzana Šestáková, PharrmDr. Peter Stanko
(2/2015, New drugs )